Paloma Partners’s Zimmer Biomet ZBH Stock Holding History

Paloma Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,900	Closed	-$2.67M	–	1108
2023 Q4	$2.67M	Sell	21,900 -1,200	-5%	-$134K	0.1%	222
2023 Q3	$2.59M	Buy	+23,100	New	+$2.93M	0.09%	195
2023 Q2	–	Sell	-6,500	Closed	-$840K	–	964
2023 Q1	$840K	Buy	+6,500	New	+$816K	0.03%	401
2019 Q3	–	Sell	-4,944	Closed	-$565K	–	2336
2019 Q2	$565K	Buy	+4,944	New	+$579K	0.01%	976
2018 Q3	–	Sell	-17,201	Closed	-$1.86M	–	2001
2018 Q2	$1.86M	Buy	+17,201	New	+$1.87M	0.03%	468
2018 Q1	–	Sell	-5,974	Closed	-$700K	–	2312
2017 Q4	$700K	Buy	5,974 +4,120	+222%	+$466K	0.01%	1211
2017 Q3	$211K	Buy	+1,854	New	+$214K	﹤0.01%	1967
2015 Q2	–	Sell	-20,600	Closed	-$2.35M	–	1966
2015 Q1	$2.35M	Buy	+20,600	New	+$2.35M	0.07%	256

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Paloma Partners's ZBH Position: Q2 2024 in Review

Paloma Partners sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 482 shares — an estimated $63.6K sold.

Paloma Partners first reported a position in ZBH in Q2 2014 and held it in 30 quarters. The position peaked at $13.1M in Q4 2021. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

Paloma Partners reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
Paloma Partners sold 482 Zimmer Biomet shares in Q2 2024, an estimated $63.6K.
Paloma Partners first reported a position in Zimmer Biomet in Q2 2014 and held it in 30 quarters.
Paloma Partners's Zimmer Biomet position peaked at $13.1M in Q4 2021.
1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Paloma Partners's 13F filing for Q2 2024, filed 14 Aug 2024.